GBSciences, Inc.

GBSciences, Inc. GB Sciences, Inc. (OTCQB: GBLX) is a phytomedicine research and biopharmaceutical drug development c GB Sciences (OTCQ GBLX) – A phytomedicine research and biopharmaceutical development company

Operating as usual

With drug development processes taking up to a 10-year span from research to marketplace, we sought out a way to increas...
11/30/2021
Gb Sciences Accelerates Drug Development via Innovative Biopharma Technology and Strategic Partnerships

With drug development processes taking up to a 10-year span from research to marketplace, we sought out a way to increase the pace to get consumers the symptom relief they need. Our efficient route includes our drug discovery platform PhAROS, a resource-efficient virtual strategy, and relationships that leverage our findings and bring them to market. Read more:

Biopharmaceutical research company pursues faster route for drug discovery using PhAROS™, Gb Sciences' AI-enabled drug discovery platform, and through efficiency in their drug development pipeline leveraging strong relationships

Our first, non-cannabis formulations will soon enter preclinical studies at the National Research Council of Canada ("NR...
11/01/2021
Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

Our first, non-cannabis formulations will soon enter preclinical studies at the National Research Council of Canada ("NRC"), testing psychotropic plant-based formulas for the treatment of both depression and anxiety. This ongoing work has produced strong and applicable data for the evaluation of its therapies, and this trial could provide novel treatment options for patients.
Read more:

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada.

The "entourage effect" in cannabis studies is the idea that plant compounds work better when they are used together rath...
09/21/2021
Harnessing the Power of Cannabis-Derived Ingredients for the Prescription Drug Market - Terpenes and Testing Magazine

The "entourage effect" in cannabis studies is the idea that plant compounds work better when they are used together rather than having one single ingredient as the star. We were featured in Terpenes & Testing Magazine discussing the mixtures of cannabis-derived ingredients that we found demonstrated molecular synergies in the treatment of specific human disorders including Parkinson’s disease, chronic pain, COVID-19-related cytokine release syndrome, and heart disease, among many others. Read the full article:

Everyone, from prominent politicians to billionaire business professionals, is lining up to capitalize on the economic value of the cannabis industry. But at Gb Sciences, we believe that cannabinoid-based medicines have significant economic potential, and we have created a therapeutic pipeline of ca...

We achieved positive proof-of-concept results affirming that our cannabinoid-containing drugs do have the potential to t...
09/14/2021
Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammation

We achieved positive proof-of-concept results affirming that our cannabinoid-containing drugs do have the potential to treat COVID-related, Cytokine Release Syndromes, which are the leading cause of death in COVID-19 patients. Our plant-based drug development program is creating and validating new therapy options at a time when thousands are dying from COVID-19. We will continue to develop our plant-inspired drugs towards a first-in-man trial, as soon as possible.
Read more:

Based on a recently completed preclinical study performed at Michigan State University, Gb Sciences' preclinical data supports further development of their novel cannabinoid-containing complex mixtures as anti-inflammatory therapies for hyperinflammatory conditions associated with COVID-19 and other...

Our President and CSO, Dr. Andrea Small-Howard, will be presenting at the H.C. Wainwright 23rd Annual Global Investment ...
09/09/2021

Our President and CSO, Dr. Andrea Small-Howard, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held on September 13-15 virtually.
Dr. Small-Howard will provide an overview of Gb Sciences' drug development pipeline of novel plant-inspired pharmaceuticals for COVID-related cytokine release syndrome, chronic pain, and Parkinson's disease and highlight our strategic advantages including PhAROS™, a proprietary, AI-enabled drug discovery platform.
Link to register: https://journey.ct.events/view/2f438f8c-7c8e-40e8-8365-5286b17d92cf
Read more: https://gbsciences.newswire.com/news/gb-sciences-presenting-covid-related-cytokine-release-syndrome-results-21493280

Our President and CSO, Dr. Andrea Small-Howard, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held on September 13-15 virtually.
Dr. Small-Howard will provide an overview of Gb Sciences' drug development pipeline of novel plant-inspired pharmaceuticals for COVID-related cytokine release syndrome, chronic pain, and Parkinson's disease and highlight our strategic advantages including PhAROS™, a proprietary, AI-enabled drug discovery platform.
Link to register: https://journey.ct.events/view/2f438f8c-7c8e-40e8-8365-5286b17d92cf
Read more: https://gbsciences.newswire.com/news/gb-sciences-presenting-covid-related-cytokine-release-syndrome-results-21493280

We're looking forward to presenting at the SNN Network Summer Virtual Event 2021 next Wednesday, August 18th. Dr. Andrea...
08/16/2021
Gb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021

We're looking forward to presenting at the SNN Network Summer Virtual Event 2021 next Wednesday, August 18th. Dr. Andrea Small-Howard, our President and Chief Science Officer will be hosting the presentation and answering questions from investors.
Full story:

LAS VEGAS, NV / ACCESSWIRE / August 10, 2021 / Gb Sciences (OTCQB:GBLX), a plant-based research and biopharmaceutical drug development company, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Wednesday, August 18th at 3:00 PM EST. Andrea Small-Howard, Presi...

After successfully testing our PhAROS drug discovery platform, we identified potentially effective therapeutic mixtures ...
08/09/2021
GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Propriet

After successfully testing our PhAROS drug discovery platform, we identified potentially effective therapeutic mixtures from within the Piper plant family. These mixtures could be used to treat anxiety, depression, and pain. Our goal is to advance these potential drug formulations into animal testing next quarter. This is the first step towards the future of using plants as medicine. Learn more:

Business GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Propriet July 27, 2021, 10:10 AM EDT SHARE THIS ARTICLEShareTweetPostEmail GB Sciences used PhAROS™, their novel AI-accelerated drug discovery platform, to identify and pre-valida...

Thank you Cannabis Business Times for including us in the podcast series, "Beyond the Show". Our President and CSO, Dr. ...
08/02/2021
Beyond the Show: Dr. Andrea Small-Howard

Thank you Cannabis Business Times for including us in the podcast series, "Beyond the Show". Our President and CSO, Dr. Andrea Small-Howard was interviewed and set the stage for her upcoming presentation at the Cannabis Conference in August 2021. Interested in learning more about the coined term "Clinical Cannabis?" Listen here and sign up for the upcoming conference: https://www.cannabisbusinesstimes.com/video/beyond-the-show-dr-andrea-small-howard/

This week, we're talking "clinical cannabis" product formulations with the president of GB Sciences in Las Vegas.

Today in TechRepublic, GB Sciences proprietary PhAROS drug discovery process is strengthened by partnering with data sci...
07/27/2021
Drug discovery company works with ethnobotanists and data scientists

Today in TechRepublic, GB Sciences proprietary PhAROS drug discovery process is strengthened by partnering with data scientists and ethnobotanists. From the article, "GB Sciences uses a human in the loop approach to AI with subject-matter experts who help to train our algorithms."
Read more: https://www.techrepublic.com/article/drug-discovery-company-works-with-ethnobotanists-and-data-scientists/

GB Sciences built a database and AI platform to analyze the healing powers of plants from nine traditional medicine practices.

"This is Going to Change the Way People Think About Medicine," said Dr. Andrea Small-Howard, our President and Chief Sci...
07/21/2021
‘This is Going to Change the Way People Think About Medicine’: Q&A with Dr. Andrea Small-Howard

"This is Going to Change the Way People Think About Medicine," said Dr. Andrea Small-Howard, our President and Chief Science Officer, during a recent interview with the Cannabis Business Times.
We are changing the game by using AI technology to bring novel medicines to market, most recently including our cannabis-based treatments for Parkinson’s disease and chronic pain.
Check out the full interview: https://www.cannabisbusinesstimes.com/article/cannabis-based-medicine-gb-sciences-andrea-small-howard

Chief Science Officer and recently appointed GB Sciences President Dr. Andrea Small-Howard details the company’s latest research in cannabis-based treatments for Parkinson’s disease and pain, and how it is using AI technology to bring novel medicines to market.

Our President and CSO, Andrea Small-Howard, will chair & speak at the Traditional Medicines Conference next week, July 1...
07/07/2021
Traditional Medicine Conference

Our President and CSO, Andrea Small-Howard, will chair & speak at the Traditional Medicines Conference next week, July 12-14, virtually.
On July 14th, her talk, entitled "Meta-pharmacopeia Assembly and Interrogation: Methods and Outputs Using the PhAROS™ Platform" will discuss how Gb Sciences has used PhAROS to develop novel therapies based on mixtures of plant-based compounds, beyond cannabis, sourced from traditional medical systems.
Link to register: https://www.traditionalmedicinesconference.com/

Traditional medicine conference 2021 includes research on alternative, herbal, naturopathic, chinese medicine, phytochemistry, medicinal plants. Doctors, practitioners, professors, students meeting on the occasion of TMED-2021.

As #biotech innovators, our goal is to lead the way towards the future of medicine: combining AI technology, plant-based...
06/29/2021

As #biotech innovators, our goal is to lead the way towards the future of medicine: combining AI technology, plant-based medicine, and hard science. Our recently launched PHAROS drug discovery platform uses data analytics and machine learning to explore and validate novel plant-based therapeutics with the potential to become pharmaceutical medicines.
Learn more: https://gbsciences.newswire.com/news/gb-sciences-using-ai-technology-in-plant-based-drug-discovery-research-21418124

As #biotech innovators, our goal is to lead the way towards the future of medicine: combining AI technology, plant-based medicine, and hard science. Our recently launched PHAROS drug discovery platform uses data analytics and machine learning to explore and validate novel plant-based therapeutics with the potential to become pharmaceutical medicines.
Learn more: https://gbsciences.newswire.com/news/gb-sciences-using-ai-technology-in-plant-based-drug-discovery-research-21418124

We're proud to welcome Gary Herman as our new Advisory Director on the board of our subsidiary GbS Global Biopharma. His...
06/23/2021
Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director

We're proud to welcome Gary Herman as our new Advisory Director on the board of our subsidiary GbS Global Biopharma. His years of experience working with undervalued growth companies and his expertise in the biopharma sector will help us to accelerate our progress in bringing our plant-inspired formulations to market.
https://gbsciences.newswire.com/news/gary-herman-joins-gb-sciences-subsidiary-gbs-global-biopharma-as-21417375

Herman will bring his experience as an investor in undervalued growth companies to this role as Advisory Director

We're proud to congratulate Andrea Small-Howard on her new role as President of Gb Sciences. This is an exciting time fo...
06/17/2021
GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President

We're proud to congratulate Andrea Small-Howard on her new role as President of Gb Sciences. This is an exciting time for our company as we continue to build tools that empower scientists to create new plant-inspired medicines. https://gbsciences.newswire.com/news/gb-sciences-board-of-directors-has-passed-a-unanimous-written-consent-21419062

The UWC also retains John Poss as Chairman and CEO of GB Sciences, Inc.

It was an honor to be invited to present our novel plant-inspired pain therapies at last week's Sachs Associates Neurosc...
05/04/2021
Dr Andrea Small Howard GB Sciences

It was an honor to be invited to present our novel plant-inspired pain therapies at last week's Sachs Associates Neuroscience Innovation Forum. Our CSO, Dr. Andrea Small-Howard had the opportunity to introduce our new company structure to the conference attendees.
Our video is now available for the public: https://www.youtube.com/watch?v=FmqYzAfsUiU

This Thursday, April 29th our very own Dr. Andrea Small-Howard will be featured at the 4th Annual Sachs Associates Neuro...
04/27/2021
GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum

This Thursday, April 29th our very own Dr. Andrea Small-Howard will be featured at the 4th Annual Sachs Associates Neuroscience Innovation Forum on a live Pain, Migraine, & Addiction panel.
We're excited to also be featured during the 20 Minute SPOTLIGHT SHOWCASE as part of the conference.

Learn more about the other speakers, attendees, and our spotlight:
https://www.newswire.com/news/gb-sciences-featured-speaking-at-the-sachs-associates-4th-annual-21364866

Dr. Andrea Small-Howard will be speaking as a part of the live Pain, Migraine & Addiction Panel on April 29 at 11:50 a.m. EDT, and she will be presenting the company during the 20-minute SPOTLIGHT SHOWCASE.

Today we announced a prefered supplier relationship with Purisys, the global industry leader in pharmaceutical-grade can...
04/20/2021
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

Today we announced a prefered supplier relationship with Purisys, the global industry leader in pharmaceutical-grade cannabinoid.

This strategic relationship will allow us to obtain supplies immediately to begin preclinical studies and develop clinical drug prototypes. This is a step towards our longer-term goals of launching clinical trials, scale-up, and eventually, commercial manufacturing.
Read the full story:
https://www.newswire.com/news/gb-sciences-and-purisys-announce-preferred-supplier-relationship-to-21366683

Purisys will supply ultra-high purity cannabinoids for use in GB Sciences' cannabinoid-containing, optimized therapeutic mixtures (OTM).

We have officially announced our patent-pending drug discovery platform, built to utilize data analytics and machine lea...
04/07/2021
GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform

We have officially announced our patent-pending drug discovery platform, built to utilize data analytics and machine learning to predict the efficacy of plant-based medicines at the intersection of hard-science, plant based medicine, and solid business practices.

Ultimately, researchers can spend less time and money getting plant-based drugs into human trials and eventually, help people to lead more naturally healthier lives.
Learn more: https://www.newswire.com/news/gb-sciences-files-provisional-patent-application-to-protect-its-21296836

#drugdiscovery #biotech #plantbased

GBS' newest proprietary drug discovery platform uses data analytics and machine learning to gain valuable predictive insights into the likely efficacy of novel plant-derived therapeutics. This unique ability allows researchers to reduce the time and money required for novel, plant-based combination....

We are excited to have been featured in Pharma's Almanac as a growing phytomedical company, shifting away from our canna...
04/06/2021
Exploring the Natural Pharmacopeia and Incubating a Biotech Company

We are excited to have been featured in Pharma's Almanac as a growing phytomedical company, shifting away from our cannabis focus to become a broader #biotech drug incubator. The article highlights not only this transition, but our strategy in creating plant-inspired, optimized therapeutic mixtures that we have patented for use in treating many diseases. Several of our leading drug candidates are in #preclinicalstudies in preparation for our first human clinical trials.

Read the full article here: https://www.pharmasalmanac.com/articles/exploring-the-natural-pharmacopeia-and-incubating-a-biotech-company

Andrea Small Howard, CSO and Director of GB Sciences, explains exploring the natural pharmacopeia of many cultures to form the basis for an innovative biotech company.

Following a successful partnership with the Universidad de Sevilla, our team completed a study describing our newly-inve...
03/24/2021
GB Sciences Publishes Study on Creation of Novel Terpene-Containing Nanoparticles for Pain Relief

Following a successful partnership with the Universidad de Sevilla, our team completed a study describing our newly-invented terpene-containing nanoparticles, which form the basis of our time-released pain formulations, published in the journal Industrial Crops and Products. The proof-of-concept study in animals is on the path towards success. Our next goal will be to prepare for FDA-registered clinical trials.

The future of pain relief is plant-based.
https://www.newswire.com/news/gb-sciences-publishes-study-on-creation-of-novel-terpene-containing-21342092

GB Sciences and their Spanish research partners at the Universidad de Sevilla (USE) have created terpene-containing nanoparticles. These first of their kind nanoparticles are central to GB Sciences' time-released pain formulations that are currently in animal trials at the NRC Canada, in preparation...

Address

Las Vegas, NV
89118

Alerts

Be the first to know and let us send you an email when GBSciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to GBSciences, Inc.:

Videos

Nearby health & beauty businesses


Other Las Vegas health & beauty businesses

Show All

Comments

What's going on!!!
Why I land to IASO's website when I press "more info" button here in Facebook? How is IASO related? Is it subsidiary? I can see Krüger there
I've invested a lot of money and time in to you. Why do you hate me?
Time is ticking on this one. and It's 4th and long with 6 seconds left. 😠
The stock is had really become frustratingon. I am 67% down after averaging down. I have no idea how it got in the 14 cent range but this needs to end.
Our Stock Price needs a life line ASAP.
excellent!
hey GBSciences, Inc. Awesome work in Louisiana. I have friends there who are visiting.. they want to know where they can buy your tincture or flower while they are in NV. They are medical and want to try what they can expect when back in LA. Where can I send them? I have reached out on twitter, phone, contact form/email with no response.. so now I am trying here.
A blessing from the Queen of Soul;
Thank You Shott, Armstead, Charmicael and Morrisey for protecting Big Pharma and bringing Medical Cannabis to West Virginia without any interference....Just look what a progressive State can do..
Press Release Distribution for OTC Markets- only $349.99! unlimited words, logos, hyperlinks & more with http://www.otcprwire.com